Fig. 3From: Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort studyCumulative incidence function after competing risk regression of any severe adverse event. Legend: Competing risk accounting for loss from treatment and death during treatment, by HIV and ART statusBack to article page